Health
STAT+: Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trial
Adam Feuerstein·STAT News·November 17, 2026

Sellas' experimental blood cancer immunotherapy reduced the risk of death in clinical trial.
Read the full story at STAT News →